Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Compound Xuanju Capsule in Unexplained Recurrent Spontaneous Abortion
ChiCTR2100042007Phase 4Completed
- Sponsor
- Weifang People's Hospital
- Start
- Feb 2016
- Countries
- 1
01
Overview
Phase 4, open-label trial of compound xuanju in recurrent miscarriage (RPL) (2 arms), sponsored by Weifang People's Hospital. Primary endpoints: T lymphocyte subsets before treatment in URSA group, T lymphocyte subsets after treatment in URSA group and 2 more. Started Feb 2016; status: completed.
02
Drugs
compound xuanju
03
Conditions
recurrent miscarriage (RPL)
Beyond the preview
Go deeper on ChiCTR2100042007.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100042007.